These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 11296098

  • 1. Anxiolyticlike effects of atrial natriuretic peptide on cholecystokinin tetrapeptide-induced panic attacks: preliminary findings.
    Wiedemann K, Jahn H, Yassouridis A, Kellner M.
    Arch Gen Psychiatry; 2001 Apr; 58(4):371-7. PubMed ID: 11296098
    [Abstract] [Full Text] [Related]

  • 2. Anxiolytic activity of atrial natriuretic peptide in patients with panic disorder.
    Ströhle A, Kellner M, Holsboer F, Wiedemann K.
    Am J Psychiatry; 2001 Sep; 158(9):1514-6. PubMed ID: 11532742
    [Abstract] [Full Text] [Related]

  • 3. Effects of repetitive transcranial magnetic stimulation (rTMS) on panic attacks induced by cholecystokinin-tetrapeptide (CCK-4).
    Zwanzger P, Eser D, Völkel N, Baghai TC, Möller HJ, Rupprecht R, Padberg F.
    Int J Neuropsychopharmacol; 2007 Apr; 10(2):285-9. PubMed ID: 16817979
    [Abstract] [Full Text] [Related]

  • 4. Increased ACTH concentrations associated with cholecystokinin tetrapeptide-induced panic attacks in patients with panic disorder.
    Ströhle A, Holsboer F, Rupprecht R.
    Neuropsychopharmacology; 2000 Mar; 22(3):251-6. PubMed ID: 10693152
    [Abstract] [Full Text] [Related]

  • 5. Anxiety modulation by the heart? Aerobic exercise and atrial natriuretic peptide.
    Ströhle A, Feller C, Strasburger CJ, Heinz A, Dimeo F.
    Psychoneuroendocrinology; 2006 Oct; 31(9):1127-30. PubMed ID: 17010527
    [Abstract] [Full Text] [Related]

  • 6. Megestrol attenuates the hormonal response to CCK-4-induced panic attacks.
    Raedler TJ, Jahn H, Goedeken B, Gescher DM, Kellner M, Wiedemann K.
    Depress Anxiety; 2006 Oct; 23(3):139-44. PubMed ID: 16470820
    [Abstract] [Full Text] [Related]

  • 7. Possible role of atrial natriuretic hormone in pituitary-adrenocortical unresponsiveness in lactate-induced panic.
    Kellner M, Herzog L, Yassouridis A, Holsboer F, Wiedemann K.
    Am J Psychiatry; 1995 Sep; 152(9):1365-7. PubMed ID: 7653695
    [Abstract] [Full Text] [Related]

  • 8. Differential effects to CCK-4-induced panic by dexamethasone and hydrocortisone.
    Demiralay C, Jahn H, Kellner M, Yassouridis A, Wiedemann K.
    World J Biol Psychiatry; 2012 Oct; 13(7):526-34. PubMed ID: 22111662
    [Abstract] [Full Text] [Related]

  • 9. Effects of alprazolam on cholecystokinin-tetrapeptide-induced panic and hypothalamic-pituitary-adrenal-axis activity: a placebo-controlled study.
    Zwanzger P, Eser D, Aicher S, Schüle C, Baghai TC, Padberg F, Ella R, Möller HJ, Rupprecht R.
    Neuropsychopharmacology; 2003 May; 28(5):979-84. PubMed ID: 12700707
    [Abstract] [Full Text] [Related]

  • 10. Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings.
    Bradwejn J, Koszycki D, Shriqui C.
    Arch Gen Psychiatry; 1991 Jul; 48(7):603-10. PubMed ID: 2069490
    [Abstract] [Full Text] [Related]

  • 11. Influence of clonidine on psychopathological, endocrine and respiratory effects of cholecystokinin tetrapeptide in patients with panic disorder.
    Kellner M, Yassouridis A, Jahn H, Wiedemann K.
    Psychopharmacology (Berl); 1997 Sep; 133(1):55-61. PubMed ID: 9335081
    [Abstract] [Full Text] [Related]

  • 12. Atrial natriuretic hormone in lactate-induced panic attacks: mode of release and endocrine and pathophysiological consequences.
    Kellner M, Knaudt K, Jahn H, Holsboer F, Wiedemann K.
    J Psychiatr Res; 1998 Sep; 32(1):37-48. PubMed ID: 9693999
    [Abstract] [Full Text] [Related]

  • 13. CCK-4: Psychophysiological conditioning elicits features of spontaneous panic attacks.
    Hinkelmann K, Yassouridis A, Mass R, Tenge H, Kellner M, Jahn H, Wiedemann K, Wolf K.
    J Psychiatr Res; 2010 Dec; 44(16):1148-53. PubMed ID: 20451215
    [Abstract] [Full Text] [Related]

  • 14. Distinct panicogenic activity of sodium lactate and cholecystokinin tetrapeptide in patients with panic disorder.
    Plag J, Gaudlitz K, Zschucke E, Yassouridis A, Pyrkosch L, Wittmann A, Holsboer F, Ströhle A.
    Curr Pharm Des; 2012 Dec; 18(35):5619-26. PubMed ID: 22632477
    [Abstract] [Full Text] [Related]

  • 15. Behavioral and endocrine response to cholecystokinin tetrapeptide in patients with posttraumatic stress disorder.
    Kellner M, Wiedemann K, Yassouridis A, Levengood R, Guo LS, Holsboer F, Yehuda R.
    Biol Psychiatry; 2000 Jan 15; 47(2):107-11. PubMed ID: 10664826
    [Abstract] [Full Text] [Related]

  • 16. Effect of aging on cholecystokinin-induced panic.
    Flint AJ, Koszycki D, Vaccarino FJ, Cadieux A, Boulenger JP, Bradwejn J.
    Am J Psychiatry; 1998 Feb 15; 155(2):283-5. PubMed ID: 9464213
    [Abstract] [Full Text] [Related]

  • 17. Effects of a metabotropic glutamate(2/3) receptor agonist (LY544344/LY354740) on panic anxiety induced by cholecystokinin tetrapeptide in healthy humans: preliminary results.
    Kellner M, Muhtz C, Stark K, Yassouridis A, Arlt J, Wiedemann K.
    Psychopharmacology (Berl); 2005 Apr 15; 179(1):310-5. PubMed ID: 15821951
    [Abstract] [Full Text] [Related]

  • 18. Copeptin - A potential endocrine surrogate marker of CCK-4-induced panic symptoms?
    Demiralay C, Agorastos A, Yassouridis A, Jahn H, Wiedemann K, Kellner M.
    Psychoneuroendocrinology; 2017 Feb 15; 76():14-18. PubMed ID: 27871026
    [Abstract] [Full Text] [Related]

  • 19. Peptides and anxiety: a dose-response evaluation of pentagastrin in healthy volunteers.
    McCann UD, Slate SO, Geraci M, Uhde TW.
    Anxiety; 2017 Feb 15; 1(6):258-67. PubMed ID: 9160584
    [Abstract] [Full Text] [Related]

  • 20. Effects of natriuretic peptides upon hypothalamo-pituitary-adrenocortical system activity and anxiety behaviour.
    Wiedemann K, Jahn H, Kellner M.
    Exp Clin Endocrinol Diabetes; 2000 Feb 15; 108(1):5-13. PubMed ID: 10768826
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.